Yingying Lin

925 citations
45 papers · 659 indexed · h-index 14
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers)Epigenetics and DNA Methylation (4 papers)Pregnancy and preeclampsia studies (3 papers)

In The Last Decade

Yingying Lin

43 papers receiving 649 citations

Peers

Yingying Lin
Comparison fields: 5 of 97
  • Molecular Biology 226
  • Immunology 137
  • Epidemiology 131
  • Oncology 111
  • Pulmonary and Respiratory Medicine 100
Replace Bomiao Cui with:
Bomiao Cui China
Yonat Shemer Avni Israel
Gertjan J. Driessen Netherlands
Wenxin Luo China
Chiao‐Ling Tsai Taiwan
Lynn Gregory France
Christopher A. Smith United Kingdom
Kevin Molloy Ireland
Thomas Böhler Germany
Branson Chen Canada
Yingying Lin relative to Bomiao Cui China Bomiao Cui's profile →
Citations per field
00.5×
Bomiao Cui · 1×
Citations per year

Countries citing papers authored by Yingying Lin

Since Specialization
Citations

This map shows the geographic impact of Yingying Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingying Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingying Lin more than expected).

Fields of papers citing papers by Yingying Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingying Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingying Lin. The network helps show where Yingying Lin may publish in the future.

Co-authorship network of co-authors of Yingying Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yingying Lin. A scholar is included among the top collaborators of Yingying Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingying Lin. Yingying Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 2
4 7
5 4
6 1
7 12
8 2
9 7
10 11
11 6
12 18
13 13
14 5
15 10
16 6
17 39
18 22
19 8
20 32

About Yingying Lin

Yingying Lin is a scholar working on Cancer Research, Obstetrics and Gynecology and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 659 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Epigenetics and DNA Methylation (4 papers) and Pregnancy and preeclampsia studies (3 papers). The work is most often cited by research in Immunology (137 citations), Cancer Research (76 citations) and Infectious Diseases (84 citations). Yingying Lin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chunfu Zheng, Martha Lee, Patricia Lester, Mary Jane Rotheram‐Borus, Hongjuan You, Qingtang Shen, Zhaolei Cui, Yan Chen, Minhua Hu and Peng Cao. Their work appears in journals such as Molecular and Cellular Biology, Chemical Communications and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026